SECUNDUM ARTEM
ActiveFrom the official registers: KBO 21 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
SECUNDUM ARTEM has been active since 2004 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €206,242 and a net result of €99,011. Equity has been growing by about 2.9% per year since 2019. Its solvency ranks better than 56% of 5,036 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
KBO- Status
- Active since 14-10-2004 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Establishment unit
- 2.144.056.920 1040 Etterbeek, since 14-10-2004
- Financial year end
- 30 September
- Peppol
- Reachable since 19-12-2025
Board and ownership
- Red One Pharma SRLDirector
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Gross margin
- €298,444
- ▲ 5.6%
- Turnover
- ≈ €1.1m
- estimated
- Profit
- €99,011
- ▼ 1.6%
- Equity
- €206,242
- ▼ 0.5%
- Total assets
- €496,587
- ▲ 5.2%
- Staff
- 2.4 FTE
- ▲ 9.1%
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 1.71, cash €286,985Founded in 2004Equity €206,242 (41.5% of total assets)Show the evidence
Checked score
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 57% of them on solvency, 76% on liquidity, 88% on profitability and 37% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 98 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
Comparable companies
These companies have the same main activity as SECUNDUM ARTEM: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €468,000 and €601,000, founded between 2001 and 2008.
| Company | Total assets | Gross margin |
|---|---|---|
| SECUNDUM ARTEM Etterbeek | €496,587 | €298,444 |
| APOTHEEK DERIDDER Halle | €488,451 | €309,100 |
| APOTHEEK DE VIJFHOEK Mechelen | €546,294 | €326,578 |
| PHARMACIE LAPERCHE Evere | €485,699 | €330,897 |
| PHARMACIE DE LA JONCTION Sint-Joost-ten-Node | €601,403 | €324,194 |
| HEALTHY PHARMACY Beersel | €468,090 | €322,202 |
| LIBO CONSULT Halen | €516,567 | €243,596 |
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 30-01-2026
- Annual accounts 2024filed on 26-02-2025
- Annual accounts 2023filed on 26-01-2024
- Annual accounts 2022filed on 23-12-2022
Acts in the Belgian Official Gazette
All publications in the Belgian Official GazetteArticles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about SECUNDUM ARTEM
- What is the company number of SECUNDUM ARTEM?
- The company number of SECUNDUM ARTEM is 0867.834.452. The VAT number is the same number with BE in front: BE 0867.834.452.
- Where is SECUNDUM ARTEM based?
- The registered office is at Elf Novemberlaan 32-4, 1040 Etterbeek.Company details
- What does SECUNDUM ARTEM do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of SECUNDUM ARTEM?
- The legal form of SECUNDUM ARTEM is Private limited company (BV).
- When was SECUNDUM ARTEM founded?
- SECUNDUM ARTEM was founded on 14-10-2004.
- Is SECUNDUM ARTEM still active?
- Yes, SECUNDUM ARTEM is an active enterprise in the KBO register.
- How many employees does SECUNDUM ARTEM have?
- SECUNDUM ARTEM had an average of 2.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of SECUNDUM ARTEM?
- The turnover in financial year 2025 is ≈ €1.1m. This figure is estimated from the gross margin of €298,444 and 47 comparable companies (NACE 477). It probably lies between €840,000 and €1.8m.
- Is SECUNDUM ARTEM profitable?
- In financial year 2025, SECUNDUM ARTEM made a profit of €99,011.
- Where can I find the annual accounts of SECUNDUM ARTEM?
- SECUNDUM ARTEM filed 21 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
- When are the next annual accounts of SECUNDUM ARTEM due?
- SECUNDUM ARTEM must file the annual accounts for financial year 2026 by 30-04-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.